Journals / Turkish Journal of Pediatrics / 2020 / Cilt: 62 - Sayı: 4

Terlipressin in the treatment of neonatal refractory hypotension caused by septic shock: a case report

Pages
668–672
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

While TP treatment appeared to help control hypotension and may prolong the survival time, there are no conclusive data regarding the safety and efficacy of TP in neonates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:While the clinical benefits of terlipressin (TP) have been reported in adults and children with refractory hypotension, data in neonates are limited.
📊
Key Findings & Data:However, genetic testing revealed mitochondrial gene defects in the patient, and the parents subsequently elected to stop treatment after 25 doses of TP (20 μg/kg/min every 4 h for 100 h).
💡
Conclusion & Impact:While TP treatment appeared to help control hypotension and may prolong the survival time, there are no conclusive data regarding the safety and efficacy of TP in neonates.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background. While the clinical benefits of terlipressin (TP) have been reported in adults and children with refractory hypotension, data in neonates are limited. Case. Herein, we report a case of off-label rescue TP therapy in a neonate with septic shock and persistent hypotension. The patient’s blood pressure was normalized, and tissue perfusion improved without serious adverse reactions. However, genetic testing revealed mitochondrial gene defects in the patient, and the parents subsequently elected to stop treatment after 25 doses of TP (20 μg/kg/min every 4 h for 100 h). Conclusion. While TP treatment appeared to help control hypotension and may prolong the survival time, there are no conclusive data regarding the safety and efficacy of TP in neonates.

🔖

Cite This Article

CHEN, Q., HUANG, Z., CHEN, Y. (2020). Terlipressin in the treatment of neonatal refractory hypotension caused by septic shock: a case report. Turkish Journal of Pediatrics, Cilt: 62 - Sayı: 4, 668–672. https://ajindex.com/articles/411923

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bidegain M, Greenberg R, Simmons C, Dang C, Cotten CM, Smith PB. Vasopressin for refractory hypotension in extremely low birth weight infants J Pediatr 2010; 157: 502-504
  2. Fanaroff AA, Fanaroff JM. Short-and long-term consequences of hypotension in ELBW infants. Semin Perinatol 2006; 30: 151-155
  3. Matok I, Vard A, Efrati O, et al. Terlipressin as rescue therapy for intractable hypotension due to septic shock in children.Shock 2005; 23: 305-310
  4. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359: 1209-1210
  5. Rodriguez-Nunez A, Oulego-Erroz I, Gil-Anton J, et al; RETSPED-II Working Group of the Spanish Society of Pediatric Intensive Care. Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock. Ann Pharmacother 2010; 44: 1545-1553
  6. Kam PC, Williams S, Yoong FF. Vasopressin and terlipressin: pharmacology and its clinical relevance Anaesthesia 2004; 59: 993-1001
  7. Yildizdas D, Yapicioglu H, Celik U, Sertdemir Y, Alhan E. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med 2008; 34: 511-517
  8. Shivanna B, Rios D, Rossano J, Fernandes CJ, Pammi M. Vasopressin and its analogues for the treatment of refractory hypotension in neonates. Cochrane Database Syst Rev 2013: CD009171
  9. Matok I, Leibovitch L, Vardi A, et al. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 2004; 5: 116-118
  10. Filippi L, Gozzini E, Daniotti M, Pagliai F, Catarzi S, Fiorini P. Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants. Pediatr Crit Care Med 2011; 12: e237-e241
  11. Radicioni M, Troiani S, Camerini PG. Effects of terlipressin on pulmonary artery pressure in a septic cooled infant: an echocardiographic assessment. J Perinatol 2012; 32: 893-895
  12. Stathopoulos L, Nicaise C, Michel F, et al. Terlipressin as rescue therapy for refractory pulmonary hypertension in a neonate with a congenital diaphragmatic hernia. J Pediatr Surg 2011; 46: e19-e21
  13. Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, González-Alonso N, MartinónSánchez JM. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 2004; 30: 477-480
  14. Zeballos G, Lopez-Herce J, Fernandez C, Brandstrup KB, Rodríguez-Núñez A. Rescue therapy with terlipressin by continuous infusion in a c